BUSINESS Senores Pharmaceuticals announces strategic joint venture in U.S. for federal sector supplies Apr 3, 2026
BUSINESS Senores Pharmaceuticals appoints Jatin Gajjar as CTO and announces resignation of Manohar Lalge Mar 17, 2026
Senores Pharmaceuticals shares jump over 4% following U.S. launch of Deferiprone Tablets USP, 500 mg & 1000 Dec 12, 2025
Senores Pharmaceuticals launches Deferiprone Tablets USP, 500 mg & 1000 mg in the U.S. market Dec 11, 2025
Senores Pharmaceuticals acquires USFDA-approved ANDA for Enalapril Maleate Tablets from Wockhardt May 20, 2025
Senores Pharmaceuticals acquires USFDA-approved ANDA for Tramadol Tablets from APDM Pharmaceuticals May 9, 2025
Senores Pharmaceuticals share price jumps 3% after company acquires ANDA for Topiramate tablets from Wockhardt May 6, 2025
Senores Pharmaceuticals acquires ANDA for Roflumilast tablets from Breckenridge Pharmaceutical Feb 20, 2025
Senores Pharmaceuticals Q3 FY25 Results: Revenue up 31% YoY to Rs 103.02 crore, Net Profit up 131% YoY Jan 23, 2025